Erectile dysfunction (ED) is associated with cardiovascular risk factors as elevated systolic blood pressure (SBP), resting high heart rate (HR), and endothelial dysfunction and predicts cardiovascular events. However, the interaction between high HR and SBP and the development of ED remains unclear.
Methods and Results
We evaluated 1015 male patients enrolled in the ED substudy of ONTARGET and TRANSCEND, examining the influence of mean HR and mean SBP obtained over all study visits (mean 10.9±1.4 study visits) and their interaction with ED. In patients without pre-existing ED, new onset ED was detected in 29% of patients below, and 41% of patients above, the median of mean HR (OR 1.72, 95% CI 1.8–2.5, p = 0.0047). In patients with pre-existing ED, high HR had no add-on effect. With or without pre-existing ED, high SBP had no influence after adjustment for covariates (OR 1.03, 95% CI 0.66–1.59, p = 0.91). In a continuous model, it was shown that effects of high HR were prominent at low Kölner (Cologne) Evaluation of Erectile Function (KEED) score baseline values and in the presence of SBP above the median.
Conclusions
In patients at risk for cardiovascular events, high HR is associated with ED, whereas the effect of high SBP was not significant. High resting HR might represent a cardiovascular risk indicator. Whether HR represents a potential treatment target to improve ED in high-risk individuals must be scrutinized in prospective trials.
NIH Consensus Development Panel on Impotence NIH Consensus Conference, Impotence. JAMA1993; 270: 83–90.
2.
ThompsonIMTangenCMGoodmanPJ. Erectile dysfunction and subsequent cardiovascular disease. JAMA2005; 294: 2996–3002.
3.
EspositoKGiuglianoFDi PaloC. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA2004; 291: 2978–2984.
4.
KlonerRASpeakmanM. Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep2002; 4: 397–401.
5.
GazzarusoCSolerteSPujiaA. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease. J Am Coll Cardiol2008; 51: 2040–2044.
6.
BöhmMBaumhäkelMTeoK. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril or both. The Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials. Circulation2010; 121: 1439–1446.
7.
Ching-WanRSoWYYangX. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol2008; 51: 2045–2050.
8.
KlonerR. Erectile dysfunction. J Am Coll Cardiol2008; 51: 2051–2052.
9.
ChobanianAVBakrisGLBlackHR. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension2003; 42: 1206–1252.
10.
LewingtonSWhitlockGClarkeR. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55000 vascular deaths. Lancet2007; 370: 1829–1839.
11.
ReilJCCustodisFSwedbergK. Heart rate reduction in cardiovascular disease and therapy. Clin Res Cardiol2011; 100: 11–19.
12.
KollochRLeglerUFChampionA. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the International Verapamil-SR/trandolapril Study (INVEST). Eur Heart J2008; 29: 1327–1334.
13.
DiazABourassaMGGuertinMC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J2005; 26: 967–974.
14.
BöhmMSwedbergKKomajdaM. SHIFT Investigators, Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomized placebo-controlled trial. Lancet2010; 376: 886–894.
15.
SolomonHManJWJacksonG. Erectile dysfunction and the cardiovascular patients: endothelial dysfunction is the common denominator. Heart2003; 89: 251–253.
16.
CustodisFSchirmerSBaumhäkelM. Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol2010; 56: 1973–1983.
17.
CustodisFBaumhäkelMSchlimmerN. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function and prevents atherosclerosis in apolipoprotein E deficient mice. Circulation2008; 117: 2377–2387.
18.
CustodisFGertzKBalkayaM. Heart rate contributes to the vascular effects of chronic mental stress: effects on endothelial function and ischemic brain injury in mice. Stroke2011; 42: 1742–1749.
19.
BaumhäkelMSchlimmerNBüyükafsarK. Nebivolol, but not metroprolol, improves endothelial function of the corpus cavernosum in apolipoprotein E-knockout mice. J Pharmacol Exp Ther2008; 325: 818–823.
20.
BaumhäkelMCustodisFSchlimmerN. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerosis plaque load in ApoE-knockout mice. Atherosclerosis2010; 212: 55–62.
21.
ONTARGET Investigators, Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med2008; 358: 1547–1559.
22.
TRANSCEND Investigators, Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial. Lancet2008; 372: 1174–1183.
23.
BöhmMBaumhäkelMProbstfieldJ. ONTARGET/TRANSCEND ED-Investigators, Sexual function, satisfaction and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND). Am Heart J2007; 154: 94–101.
24.
BraunMWassmerGKlotzT. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res2000; 12: 305–311.
25.
SolomonHManJWJacksonG. Erectile dysfunction and the cardiovascular patients: endothelial dysfunction is the common denominator. Heart2003; 89: 251–253.
26.
BillupsKL. Endothelial dysfunction as a common link between erectile dysfunction and cardiovascular disease. Current Sexual Health Reports2004; 1: 137–141.
27.
DüsingR. Sexual dysfunction in male patients with hypertension. Influence of antihypertensive drugs. Drugs2005; 66: 772–786.
28.
BaumhäkelMSchlimmerNBöhmM. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res2008; 20: 493–500.
29.
BaumhäkelMSchlimmerNKratzM. Cardiovascular risk, drugs and erectile function – a systematic analysis. Int J Clin Pract2011; 65: 289–298.
30.
GrimmRH JrGranditisGAPrineasRJ. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: treatment of mild hypertension study (TOMHS). Hypertension1997; 28: 8–14.
31.
BlankerMHBoschJLGroeneveldFP. Erectile and ejaculatory dysfunction in a community-based sample of men 50–78 years old: prevalence, concern, and relation to sexual activity. Urology2001; 57: 763–768.
32.
García-LópezMMartínez-GonzálezMBasterra-GortariF. Adherence to the Mediterranean dietary pattern and heart rate in the SUN project. Eur J Prev Cardiol2012, Epub ahead of print.
33.
BöhmMReilJ-RDanchinN. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH. J Hypertens2008; 26: 18–25.
34.
BöhmMThoenesMNeubergerH–R. Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. Eur Heart J2009; 30: 1364–1371.
35.
PössJUkenaCMahfoudF. Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH. Eur J Prev Cardiol2012; 19: 1066–1073.
36.
BöhmMCottonDFosterL. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J2012; 33: 2804–2812.
